These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30991934)

  • 1. Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.
    Dunn S; Lombardi O; Lukoszek R; Cowling VH
    Open Biol; 2019 Apr; 9(4):190052. PubMed ID: 30991934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1-Cyclin B1 Activates RNMT, Coordinating mRNA Cap Methylation with G1 Phase Transcription.
    Aregger M; Kaskar A; Varshney D; Fernandez-Sanchez ME; Inesta-Vaquera FA; Weidlich S; Cowling VH
    Mol Cell; 2016 Mar; 61(5):734-746. PubMed ID: 26942677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc co-ordinates mRNA cap methylation and ribosomal RNA production.
    Dunn S; Lombardi O; Cowling VH
    Biochem J; 2017 Feb; 474(3):377-384. PubMed ID: 27934633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cap methyltransferase (RNMT) N-terminal non-catalytic domain mediates recruitment to transcription initiation sites.
    Aregger M; Cowling VH
    Biochem J; 2013 Oct; 455(1):67-73. PubMed ID: 23863084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAM function is dependent on Kapβ2-mediated nuclear entry.
    Gonatopoulos-Pournatzis T; Cowling VH
    Biochem J; 2014 Feb; 457(3):473-84. PubMed ID: 24200467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA cap methyltransferases RNMT and CMTR1 co-ordinate gene expression during neural differentiation.
    Liang S; Almohammed R; Cowling VH
    Biochem Soc Trans; 2023 Jun; 51(3):1131-1141. PubMed ID: 37145036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double
    Vasan N; Razavi P; Johnson JL; Shao H; Shah H; Antoine A; Ladewig E; Gorelick A; Lin TY; Toska E; Xu G; Kazmi A; Chang MT; Taylor BS; Dickler MN; Jhaveri K; Chandarlapaty S; Rabadan R; Reznik E; Smith ML; Sebra R; Schimmoller F; Wilson TR; Friedman LS; Cantley LC; Scaltriti M; Baselga J
    Science; 2019 Nov; 366(6466):714-723. PubMed ID: 31699932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA Cap Methyltransferase, RNMT-RAM, Promotes RNA Pol II-Dependent Transcription.
    Varshney D; Lombardi O; Schweikert G; Dunn S; Suska O; Cowling VH
    Cell Rep; 2018 May; 23(5):1530-1542. PubMed ID: 29719263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of allosteric activation of human mRNA cap methyltransferase (RNMT) by RAM: insights from accelerated molecular dynamics simulations.
    Bueren-Calabuig JA; G Bage M; Cowling VH; Pisliakov AV
    Nucleic Acids Res; 2019 Sep; 47(16):8675-8692. PubMed ID: 31329932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mRNA capping in the cell cycle.
    Aregger M; Cowling VH
    RNA Biol; 2017 Jan; 14(1):11-14. PubMed ID: 27791484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.
    Toska E; Osmanbeyoglu HU; Castel P; Chan C; Hendrickson RC; Elkabets M; Dickler MN; Scaltriti M; Leslie CS; Armstrong SA; Baselga J
    Science; 2017 Mar; 355(6331):1324-1330. PubMed ID: 28336670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation.
    Galloway A; Kaskar A; Ditsova D; Atrih A; Yoshikawa H; Gomez-Moreira C; Suska O; Warminski M; Grzela R; Lamond AI; Darzynkiewicz E; Jemielity J; Cowling VH
    Nucleic Acids Res; 2021 Jul; 49(12):6722-6738. PubMed ID: 34125914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition.
    Spangle JM; Von T; Pavlick DC; Khotimsky A; Zhao JJ; Roberts TM
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24427-24433. PubMed ID: 32929011
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and Characterization of the Interaction Between the Methyl-7-Guanosine Cap Maturation Enzyme RNMT and the Cap-Binding Protein eIF4E.
    Osborne MJ; Volpon L; Memarpoor-Yazdi M; Pillay S; Thambipillai A; Czarnota S; Culjkovic-Kraljacic B; Trahan C; Oeffinger M; Cowling VH; Borden KLB
    J Mol Biol; 2022 Mar; 434(5):167451. PubMed ID: 35026230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
    Ippen FM; Grosch JK; Subramanian M; Kuter BM; Liederer BM; Plise EG; Mora JL; Nayyar N; Schmidt SP; Giobbie-Hurder A; Martinez-Lage M; Carter SL; Cahill DP; Wakimoto H; Brastianos PK
    Neuro Oncol; 2019 Nov; 21(11):1401-1411. PubMed ID: 31173106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.
    Sanchez CG; Ma CX; Crowder RJ; Guintoli T; Phommaly C; Gao F; Lin L; Ellis MJ
    Breast Cancer Res; 2011 Mar; 13(2):R21. PubMed ID: 21362200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.
    Beaver JA; Gustin JP; Yi KH; Rajpurohit A; Thomas M; Gilbert SF; Rosen DM; Ho Park B; Lauring J
    Clin Cancer Res; 2013 Oct; 19(19):5413-22. PubMed ID: 23888070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CA
    Liu XL; Liu JL; Xu YC; Zhang X; Wang YX; Qing LH; Guo W; Ding J; Meng LH
    Int J Cancer; 2019 Aug; 145(3):817-829. PubMed ID: 30671946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.